Matei Ionita

Matei Ionita

Auto-generated profile, based on publicly available information

Matei Ionita

Institute for Immunology & Immune Health (I3H), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MLMatthew E. Lee
Matthew E. Lee
JKJaesik Kim
Jaesik Kim
MIMatei Ionita
Matei Ionita
MMMichelle L. McKeague
Michelle L. McKeague
JLJonghyun Lee
Jonghyun Lee
EWE. John Wherry
E. John Wherry
The human immune system is composed of ∼30-50 distinct cell types, each of which can exist in different states of activation or differentiation. Indeed, the mammalian immune system has evolved to sense and respond to infections, cancers, injuries, and changes in tissue or host homeostasis (1). Moreover, an increasingly large fraction of approved drugs target the immune system directly, and/or cause immune changes (2–4). A key feature of the immune system is to store some of this information, for example as innate or adaptive immune memory (5). In addition, rewiring of immune network architecture induced by disease, environmental exposures, drug treatments, and/or chronological age allows the immune system to store information in the pattern of connections and activity across populations of immune cells. This ensemble information storage, in addition to changes to individual cells, functions as a major way the immune system encodes aspects of immune history and future potential. Genetic information can identify inherited risk alleles, but cannot capture the continual remodeling of the immune system shaped by exposures, infection, inflammation, therapy, and aging (6, 7). To define and use such ensemble immunotypes, we developed a self-supervised deep learning framework that transforms high-dimensional immune profiles into representations of immune health. MAESTRO (MAsked Encoding Set TRansformer with self-distillatiOn) encodes a set of cells from an individual into an embedding that captures immune cell population-level organization. Pretrained on 1,792 peripheral blood samples comprising over 418 million immune cells across 13 clinical diagnoses, MAESTRO learns immune fingerprints that are stable within individuals yet diverse across populations, states of health, disease, and treatment, providing a quantitative basis for comparing immune states across individuals and over time. These fingerprints capture immune architecture beyond coarse cell type proportions, enabling patient-efficient clinical prediction using simple task specific models. MAESTRO model embeddings retain a temporal dimension of immune history and potential, reflecting signatures of past exposures and baseline features that predict future immune responses. Finally, we demonstrate a translational precision immunotherapy application by testing this approach in metastatic Pancreatic Ductal Adenocarcinoma (PDAC), where pretreatment immune landscape circuitry maps enable patient stratification and therapeutic response prediction. Overall, we developed a large, attention-based model that captures deep network architecture of immune states through self- supervised representations of immune cytometry data as a reusable foundation for precision immunology, converting immune complexity into clinically actionable embeddings for diagnosis, monitoring, and therapy selection.

21 January 2021 in Cytometry Part A
Verified
Journal Article
Open access
PDF file
MIMatei Ionita
Matei Ionita
RSRichard Schretzenmair
Richard Schretzenmair
DJDerek Jones
Derek Jones
JMJonni Moore
Jonni Moore
LWLi‐San Wang
Li‐San Wang
WRWade Rogers
Wade Rogers
Automated clustering workflows are increasingly used for the analysis of high parameter flow cytometry data. This trend calls for algorithms which are able to quickly process tens of millions of data points, to compare results across subjects or time points, and to provide easily actionable interpretations of the results. To this end, we created Tailor, a model‐based clustering algorithm specialized for flow cytometry data. Our approach leverages a phenotype‐aware binning scheme to provide a coarse model of the data, which is then refined using a multivariate Gaussian mixture model. We benchmark Tailor using a simulation study and two flow cytometry data sets, and show that the results are robust to moderate departures from normality and inter‐sample variation. Moreover, Tailor provides automated, non‐overlapping annotations of its clusters, which facilitates interpretation of results and downstream analysis. Tailor is released as an R package, and the source code is publicly available atwww.github.com/matei-ionita/Tailor.

9 October 2025 in Cytometry Part A
Verified
Journal Article
Open access
MIMatei Ionita
Matei Ionita
MMMichelle L. McKeague
Michelle L. McKeague
MPMark M. Painter
Mark M. Painter
DMDivij Mathew
Divij Mathew
APAjinkya Pattekar
Ajinkya Pattekar
AGAllison R. Greenplate
Allison R. Greenplate
Flow and mass cytometry experiments are essential for profiling immune cells at single‐cell resolution. Better understanding of human immunology increasingly involves analyzing studies at the scale of hundreds or thousands of samples, with data analysis a significant bottleneck. This trend increases the demand for automated analysis methods. In particular, a common preprocessing step in cytometry data analysis is distinguishing single cells from doublets (or multiplets), events in which two (or more) cells pass simultaneously through the detector. Typically, doublets are identified on two‐dimensional density plots, using their high measured values for DNA intercalators (mass cytometry) or scattering channels (flow cytometry). Despite its popularity, this bivariate gating method is sometimes imprecise: for example, we show that bivariate gating of mass cytometry data can mistake single eosinophils for doublets, due to their high DNA content. Taking inspiration from methods already used in single‐cell transcriptomics, but not in the cytometry community, we propose an alternative approach. Our method, called Cleanet, first simulates doublet events, then identifies true events with protein expression similar to the simulated doublets. This simple method is completely automated and detects both homotypic and heterotypic doublets. We validate it in datasets acquired with mass and flow cytometry; moreover, we verify with imaging flow cytometry data from ImageStream and Discover A8 instruments that most events predicted to be doublets truly consist of multiple cells. Cleanet can also classify doublets based on their component cell types, which potentially enables the study of cell–cell interactions, mining extra information out of doublet events that would otherwise be discarded. As a proof of concept, we demonstrate that Cleanet can detect a treatment‐specific increase in interactions between two cell lines. By automating doublet detection and classification, we aim to streamline the data analysis in large cytometry studies and provide a more accurate picture of both immune cell populations and cell–cell interactions.

14 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
MIMatei Ionita
Matei Ionita
MMMichelle L. McKeague
Michelle L. McKeague
MPMark M. Painter
Mark M. Painter
DMDivij M Mathew
Divij M Mathew
APAjinkya Pattekar
Ajinkya Pattekar
AGAllison R. Greenplate
Allison R. Greenplate
Flow and mass cytometry experiments are essential for profiling immune cells at single cell resolution. Better understanding of human immunology increasingly involves analyzing studies at the scale of hundreds or thousands of samples, with data analysis a significant bottleneck. This trend increases the demand for automated analysis methods. In particular, a common preprocessing step in cytometry data analysis is distinguishing single cells from doublets (or multiplets), events in which two (or more) cells pass simultaneously through the detector. Typically, doublets are identified on two-dimensional density plots, using their high measured values for DNA intercalators (mass cytometry) or scattering channels (flow cytometry). Despite its popularity, this bivariate gating method is sometimes imprecise: for example, we show that bivariate gating of mass cytometry data can mistake single eosinophils for doublets, due to their high DNA content. Taking inspiration from methods already used in single cell transcriptomics, but not in the cytometry community, we propose an alternative approach. Our method, called Cleanet, first simulates doublet events, then identifies true events with protein expression similar to the simulated doublets. This simple method is completely automated and detects both homotypic and heterotypic doublets. We validate it in datasets acquired with mass and flow cytometry; moreover, we verify with imaging flow cytometry that events predicted to be doublets truly consist of multiple cells. Cleanet can also classify doublets based on their component cell types, which potentially enables the study of cell-cell interactions, mining extra information out of doublet events that would otherwise be discarded. As a proof of concept, we demonstrate that Cleanet can detect a treatment-specific increase in interactions between two cell lines. By automating doublet detection and classification, we aim to streamline the data analysis in large cytometry studies and provide a more accurate picture of both immune cell populations and cell-cell interactions.

3 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
PKPavel P. Kuksa
Pavel P. Kuksa
MIMatei Ionita
Matei Ionita
LCLuke Carter
Luke Carter
JCJeffrey Cifello
Jeffrey Cifello
KCKaylyn Clark
Kaylyn Clark
LWLi-San Wang
Li-San Wang
Motivation: Summary statistics from genome-wide association studies (GWAS) are widely used in fine-mapping and colocalization analyses to identify causal variants and their enrichment in functional contexts, such as affected cell types and genomic features. With the expansion of functional genomic (FG) datasets, which now include hundreds of thousands of tracks across various cell and tissue types, it is critical to establish scalable algorithms integrating thousands of diverse FG annotations with GWAS results. Results: We propose BTS (Bayesian Tissue Score), a novel, highly efficient algorithm uniquely designed for 1) identifying affected cell types and functional elements (context-mapping) and 2) fine-mapping potentially causal variants in a context-specific manner using large collections of cell type-specific FG annotation tracks. BTS leverages GWAS summary statistics and annotation-specific Bayesian models to analyze genome-wide annotation tracks, including enhancers, open chromatin, and histone marks. We evaluated BTS on GWAS summary statistics for immune and cardiovascular traits, such as Inflammatory Bowel Disease (IBD), Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), and Coronary Artery Disease (CAD). Our results demonstrate that BTS is over 100x more efficient in estimating functional annotation effects and context-specific variant fine-mapping compared to existing methods. Importantly, this large-scale Bayesian approach prioritizes both known and novel annotations, cell types, genomic regions, and variants and provides valuable biological insights into the functional contexts of these diseases. Availability and implementation: Docker image is available at https://hub.docker.com/r/wanglab/bts with pre-installed BTS R package ( https://bitbucket.org/wanglab-upenn/BTS-R ) and BTS GWAS summary statistics analysis pipeline ( https://bitbucket.org/wanglab-upenn/bts-pipeline ).

26 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JKJaesik Kim
Jaesik Kim
BLByounghan Lee
Byounghan Lee
NANamhyuk Ahn
Namhyuk Ahn
MIMatei Ionita
Matei Ionita
MMMichelle L. McKeague
Michelle L. McKeague
DKDokyoon Kim
Dokyoon Kim
In cytometry, the workhorse single-cell technology of clinical immunology, every study defines its own antibody panel and cell-type vocabulary, so a classifier trained on one cannot annotate the next. Immunologists instead annotate by manual gating, splitting one parent population at a time on a two-marker plot, down an expert-defined hierarchy. We introduce CytoGate-Bench, a benchmark that reformulates this per-step procedure as a zero-shot, panel-agnostic task for large language models. It comprises 23,646 expert-annotated instances re-curated from 11 public flow- and mass-cytometry cohorts spanning eight marker panels. Across six open- and closed-weight backbones, the strongest formulation draws one rectangular gate per candidate and falls within the range of trained, panel-specialized baselines. It degrades less under distribution shift. Walking the hierarchy stepwise outperforms predicting every cell type at once. Ablations trace the signal to the data distribution shape and curated marker priors. However, adding vision or a self-verification loop systematically tightens gates.